Posters display III clinical outcome and PET
✍ Scribed by N. Nestor Perez Baliño; O. Masoli; S. Traverso; L. Grynberg; C. Rappallo; M. Redruello; D. Rosa; D. Cragnolino; A. Meretta; L. Vidal
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 255 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1071-3581
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The trifunctional antibody catumaxomab is a targeted immunotherapy for the intraperitoneal treatment of malignant ascites. In a Phase II/III trial in cancer patients (__n__ = 258) with malignant ascites, catumaxomab showed a clear clinical benefit __vs__. paracentesis and had an acceptable safety pr
## Abstract ## Background and Objectives The KYOCERA Physio Hinge Total Knee System Type III (PHKIII) was developed to reconstruct bony defects of the distal femur. The PHKIII is originative in that the metallic parts are fully made of titanium alloy, and this prosthesis has a unique semi‐rotating